In terms of revenue, the worldwide market of diagnostic testing was valued at USD 203.24 billion in 2024 and is forecasted to cross USD 264.12 billion by 2033. The increasing prevalence of chronic diseases, growing demand for early disease detection, and advancements in diagnostic technologies are driving the growth of the diagnostic testing market.
This Report is Readily Available for Immediate Delivery | Download the Sample Pages of this Report@ https://www.precedenceresearch.com/sample/1984
Market Overview and Growth Drivers
Diagnostic testing involves the analysis of biological samples such as blood, urine, or tissues to detect diseases, monitor health conditions, and guide treatment decisions. The global demand for diagnostic testing solutions increases, as preventive healthcare strategies, and rising individualized medicine programs alongside a growing senior citizen demographic. Noncommunicable diseases (NCDs) caused at least 43 million deaths in 2021, representing 75% of global non-pandemic-related fatalities, according to a 2024 WHO report.
This underscores the urgent need for rapid disease detection and preventive healthcare measures. The need for fast and precise diagnostic results from point-of-care testing has created rising market demand which enhances market expansion. The diagnostic testing environment has undergone a revolution because these technological developments enable prompt disease identification and individualized treatment solutions.
Impact of Artificial Intelligence on Diagnostics Testing Market
The diagnostic testing market achieves smarter diagnoses with faster results and higher accuracy through the use of Artificial Intelligence (AI). Medical information of all kinds is efficiently analyzed by AI algorithms that lead to both exact disease recognition and exact diagnostic outcomes.
Portability in point-of-care testing advances because AI systems operate portable diagnostic devices that produce swift and correct outcomes allowing better patient care outside hospitals. The growth of demand for state-of-the-art diagnosis tools drives AI to develop better diagnostic capabilities which improves testing accessibility.
View Full Insight@ https://www.precedenceresearch.com/diagnostic-testing-market
Diagnostic Testing Market Key Takeaways
🔹 North America led the global market with the highest market share in 2024.
🔹 The in-vitro diagnostic instrument segment has held the highest market share in 2024.
🔹 The cardiology segment captured the biggest market share in 2024.
🔹 The hospitals segment registered the maximum market share in 2024.
Emerging Trends in the Diagnostic Testing Market
Growing Adoption of Home Testing Kits
The rising trend of self-testing and home diagnostics is driving the demand for user-friendly and portable diagnostic devices. Changes in personal healthcare delivery patterns make home testing kits for chronic diseases and infectious pathogens more acceptable for routine use.
The self-testing kit demand is growing, as users have become more aware and find these tests convenient to use. Home diagnostic devices in Asia Pacific experienced an increase, as the population faced higher chronic disease rates along with expanding healthcare centers. Home diagnostic testing continues to gain prominence because consumers now have access to proactive healthcare strategies through self-testing solutions.
Advancements in Molecular Diagnostics
Innovations in molecular diagnostics, including next-generation sequencing (NGS) and PCR technologies, are revolutionizing disease detection and personalized treatment. The molecular diagnostic product market expands through these recently developed technological advancements. WHO reports (2023) that next-generation sequencing (NGS) technology utilization exploded by 25% during that year due to its contributions to precision medicine and patient-specific treatment delivery.
Market expansion accelerates, as modern molecular diagnostics utilizes automation together with digitalization to generate better accuracy and higher operational efficiency. Recent market trends demonstrate that molecular diagnostics play a central role in both early disease diagnosis and personalized medicine practice and better patient treatment results.
Integration of Digital Pathology
Digital pathology is gaining traction with the integration of artificial intelligence and cloud computing for image analysis and data management. The modern pathology industry benefits from better medical diagnostics and efficient workflow because of this approach. WHO reports digital pathology solution adoption increased by 27% worldwide in 2023, as healthcare professionals need remote diagnostics while using telepathology services.
Cloud-based digital pathology systems achieved a worldwide growth rate of 28% for platform deployment due to their support of healthcare system data management and their ability to enhance collaboration and interoperability as per the WHO 2023 report. Medical pathology receives revolutionary changes through advancements that boost work processes while supporting individualized medical treatment.
Diagnostic Testing Market Report Coverage
|
Report Attributed |
Key Statistics |
|
Market Size in 2024 |
USD 203.24 Billion |
|
Market Size in 2025 |
USD 207.96 Billion |
|
Market Size by 2034 |
USD 272.98 Billion |
|
CAGR from 2025 to 2034 |
3% |
|
Leading Region |
North America |
|
Base Year |
2024 |
|
Forecast Period |
2025 to 2034 |
|
Segments Covered |
Type, Application, Approach, Solution, Technology, Mode of Testing, Sample Type, Testing Type, Age, Distribution Channel, End User, and Regions |
|
Regions Covered |
North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Diagnostic Testing Market Key Regional Analysis
North America dominated the global diagnostic testing market due to advanced healthcare infrastructure, high adoption of innovative diagnostic technologies, and favorable reimbursement policies. The number of persistent health problems alongside heightened healthcare costs has boosted market expansion in this geographic area. Research by the Centers for Disease Control and Prevention (CDC) 2023 report shows that 6 out of every 10 adults in the U.S. suffer from heart disease and cancer along with diabetes resulting in a greater need for developed screening solutions.
The healthcare costs in the U.S. during 2024 surpassed USD 4.9 trillion with a 7.5% annual increase while spending notably on diagnostic testing and chronic disease management according to the Centers for Medicare & Medicaid Services 2024 report. The North American market experienced an increase in point-of-care testing during 2023, as healthcare professionals needed instant precise results for emergency and primary care facilities, thus fuelling the market in this region.
Asia Pacific is anticipated to witness substantial growth during the forecast period, driven by rising healthcare investments, improving healthcare infrastructure, and increasing awareness about early disease detection. Countries like China and India, with large populations and high disease burdens, are contributing significantly to regional market growth. The World Health Organization reports a 24% rise in Asia Pacific healthcare spending for 2023 through investments in diagnostic testing infrastructure along with advanced medical technologies.
Diagnostic testing solutions registered an increase in China during 2023, as escalating chronic disease rates and government programs to increase healthcare services access. The region experiences growing middle-class demographics with simultaneously increasing healthcare prevention consciousness that drives increasing demand for sophisticated diagnostic solutions.
Diagnostic Testing Market Segmentation Outlook
Type Outlook
Home diagnostics segment is observed to grow at a significant rate in the market owing to the convenience of self-testing and the growing trend of patient-centric healthcare. The technology provides economic benefits together with rapid diagnosis protocols that help patients track diseases and their conditions effectively. Clinical Diagnostic is experiencing significant growth due to rising chronic disease prevalence, increasing demand for early and accurate diagnosis, and advancements in diagnostic technologies. This segment expands because of the widespread adoption of personal medicine approaches and treatment-specific therapeutic strategies.
Application Outlook
Cardiology diagnostics dominated due to the high prevalence of cardiovascular diseases globally. Routine monitoring and management of heart conditions drive consistent demand.
Oncology diagnostics are growing rapidly due to advancements in cancer biomarkers and early detection methods. Heart condition monitoring both for diagnostic purposes and management needs leads to stable demand patterns.
Approach Outlook
In-vitro diagnostic Instrument dominates the market due to its dependable accuracy paired with thorough diagnostic capabilities and consistent reliability. The technique maintains its status as the most trusted diagnostic tool employed in laboratories for multiple disease measurements. The market shares remain concentrated in routine blood testing as well as diagnostic testing for infectious diseases and cancer screening needs.
Point of care testing instruments is growing rapidly due to its ability to provide quick and decentralized diagnostic results. The device finds wide application because of its convenient emergency use and deployment in areas without adequate medical facilities. The growth of this market expands due to its ability to integrate with digital health platforms for remote patient monitoring.
Solution Outlook
Products dominate the market due to continuous technological advancements and the availability of a wide range of diagnostic tools. Product developments coupled with precision enhancements create more demand for these products.
Services are growing rapidly with the increasing demand for diagnostic consultations and personalized care. Telemedicine together with virtual consultation methods creates greater opportunities within diagnostic services. The market expands due to the practice of healthcare organizations outsourcing their diagnostic service requirements.
Technology Outlook
Immunoassay-based technology dominates the market, as this technology is extensively used for infectious disease diagnosis hormone testing and chronic disease management. The technology leads in the market because of its high sensitivity and specificity combined with scalability features.
PCR-Based diagnostics are growing rapidly due to high precision and sensitivity in genetic testing and infectious disease detection. The market demand increases, as PCR-Based diagnostics effectively detect newly emerging infectious diseases, such as pandemics. Digital PCR technology offers more accurate results along multiple test capabilities due to its advanced design characteristics.
Mode of Testing Outlook
Prescription based testing dominates the market due to its requirement for specialized diagnostics and clinical interpretation. The prescription-based diagnostic approach maintains its position as the primary diagnostic standard for difficult disease assays extending to oncology and neurology fields. Healthcare professionals participate in tests through their involvement to ensure both test precision and reliable analysis.
The OTC testing segment is growing rapidly due to rising consumer awareness and preference for convenient self-testing. The rising trend of preventive diagnostics combined with home-based healthcare services increases market demand. The market receives growth support from user-friendly test kits and their increased availability.
Sample Type Outlook
Blood testing segment dominated the market due to its accuracy and comprehensive diagnostic results across multiple conditions. The medical community views this testing standard as the primary approach for biochemical and hematological together with molecular diagnostic examinations.
The high clinical need for blood tests cancer marker examinations and infectious disease diagnosis tests keeps blood diagnostics at the forefront of diagnostics. The saliva testing segment is growing due to its non-invasive nature and ease of collection. Infectious disease and genetic screening together with hormone testing make up its expanding use. At-home testing kits as well as remote diagnostic systems drive the expansion of the market. Saliva-based diagnostic technology performs better due to new developments that improve both sensitivity and accuracy levels.
Testing Type Outlook
Biochemistry segments dominate, as it is a routine application in disease management and health monitoring. Medical practitioners can verify diseases precisely and track diseases sensitively with their help. The market demand increases because of its usage in oncology treatments along with infectious disease diagnoses and inherited disorders diagnoses.
The molecular diagnostic segment is growing rapidly with the rise of precision medicine and genetic testing. The testing range extends from liver function to kidney function to metabolic tests. The high demand for chronic disease management of diabetes and cardiovascular diseases strengthens its position in the market.
Age Outlook
Adult & geriatric segment dominated the market due to a larger patient base and high prevalence of chronic diseases. Diagnostic approaches that do not require invasive procedures make it easier for children to adopt these testing methods. The healthcare sector focuses more on preventive care for newborns and children which results in market expansion.
The pediatric diagnostics segment is growing due to advancements in genetic and metabolic disorder testing. The growing awareness of newborn screening programs creates a higher market demand. A growing number of pediatric infectious conditions stimulates market expansion.
Browse More Insights:
🔹 Artificial Intelligence in Diagnostics Market: https://www.precedenceresearch.com/artificial-intelligence-diagnostics-market
🔹 Precision Diagnostics Market: https://www.precedenceresearch.com/precision-diagnostics-market
🔹 Rapid Diagnostics Market: https://www.precedenceresearch.com/rapid-diagnostics-market
🔹 Blood Testing Market: https://www.precedenceresearch.com/blood-testing-market
🔹 U.S. In Vitro Diagnostics Market: https://www.precedenceresearch.com/us-in-vitro-diagnostics-market
🔹 Point-of-Care Infectious Disease Diagnostics Market: https://www.precedenceresearch.com/point-of-care-infectious-disease-diagnostics-market
🔹 Cancer Diagnostics Market: https://www.precedenceresearch.com/cancer-diagnostics-market
🔹 Infectious Disease Diagnostics Market: https://www.precedenceresearch.com/infectious-disease-diagnostics-market
🔹 Tissue Diagnostics Market: https://www.precedenceresearch.com/tissue-diagnostics-market
🔹 Colorectal Cancer Diagnostics Market: https://www.precedenceresearch.com/colorectal-cancer-diagnostics-market
Diagnostic Testing Market Companies
• ACON Laboratories Inc. (US)
• ARKRAY USA, Inc. (US)
• BD (US)
• Biohit Oyj (Finland)
• BIOMEDOMICS INC (US)
• bioMérieux SA (France)
• Bio-Rad Laboratories, Inc. (US)
• BODITECH MED INC. (South Korea)
• Chembio Diagnostic Systems, Inc. (US)
• Danaher (US)
• DiaSorin S.p.A. (Italy)
• EKF Diagnostics Holdings plc (UK)
• F-Hoffman La-Rcohe Ltd. (Switzerland)
• Grifols, S.A (Spain)
• Hemosure, Inc. (US)
• Illumina, Inc. (US)
• Lamdagen Corporation (US)
• LifeSign LLC. (US)
• Medixbiochemica (Finaland)
• MicroGen Diagnostics (US)
• Nanoentek (South Korea)
• Nova Biomedical (US)
• Ortho Clinical Diagnostics (US)
• PerkinElmer Inc. (US)
• Quidel Corporation (US)
• Sannuo Biosensing Co., Ltd. (US)
• Siemens Healthcare GmbH (Germany)
• STRECK (US)
• Sysmex Corporation (Japan)
• Thermo Fisher Scientific Inc. (US)
Developments Around the World
• In December 2024, BD and Babson Diagnostics announced an expansion of fingertip blood collection and testing technologies for U.S. health systems, including urgent care and doctor offices.
• In November 2024, Augurex Life Sciences Corp. introduced the Anti-14-3-3eta Multiplex Analyte Specific Reagents (ASRs) for a diagnostic test for axial spondyloarthritis (axSpA). New Day Diagnostics in Knoxville, TN, developed this test to help clinicians identify axSpA earlier, potentially improving patient outcomes.
• In October 2024, the World Health Organization (WHO) approved the first mpox in vitro diagnostic test for emergency use. The Alinity m MPXV assay, produced by Abbott Molecular Inc., aims to enhance diagnostic capacity in countries facing pox outbreaks.
• In August 2024, MP Biomedicals launched new rapid tests for infectious diseases, enabling accurate detection of Helicobacter pylori, Salmonella typhi, and Vibrio cholerae serogroups. These diagnostic kits aim to improve early detection and patient outcomes.
• In January 2025, Co-Diagnostics, Inc. will participate in Nasdaq’s "Live from MarketSite" broadcast during the Silicon Slopes Summit 2025. CEO Dwight Egan will discuss the Co-Dx PCR platform and its tests for COVID-19, tuberculosis, HPV, and other infectious diseases, emphasizing the company's readiness for future health crises.
Segments covered in the report
By Type
• Clinical Diagnostic
• Home Diagnostic
By Application
• Cardiology
• Oncology
• Neurology
• Orthopedics
• Gastroenterology
• Gynecology
• Odontology
• Others
By Approach
• Molecular Diagnostic Instrument
• In-Vitro Diagnostic Instrument
• Point Of Care Testing Instrument
By Solution
• Services
• Products
By Technology
• Immunoassay-Based
• PCR-Based
• Next-generation Sequencing
• Spectroscopy-Based
• Chromatography-Based
• Microfluidics
• Substrate Technology
• Others
By Mode of Testing
• Prescription Based Testing
• OTC Testing
By Sample Type
• Urine
• Saliva
• Blood
• Hair
• Sweat
• Others
By Testing Type
• Biochemistry
• Hematology
• Microbiology
• Histopathology
• Others
By Age
• Pediatric
• Adult & Geriatric
By Distribution Channel
• Direct Tenders
• Retail Sales
• Online Sales
By End User
• Hospitals, Diagnostic Center
• Research Labs and Institutes
• Research Institute • Homecare
• Blood Banks
• Specialty Clinics
• Ambulatory Surgical Centers
• Others
By Region
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)
Immediate Delivery Available | Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/1984
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 804 441 9344
Precedence Research offers exclusive subscription services designed to provide in-depth data and analytics insights. With a subscription, you gain access to a comprehensive suite of statistical resources, market intelligence, and research tools tailored to your business needs. Whether you're looking for industry trends, competitive analysis, or future market projections, our subscription plans ensure you stay ahead with reliable, up-to-date information.
Browse Our Subscription Plans@ https://www.precedenceresearch.com/get-a-subscription
About Us
Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
Web: https://www.precedenceresearch.com
Our Blogs:
Towards Healthcare | Towards Packaging | Statifacts | Towards EV Solutions | Towards Dental | Towards Automotive | Nova One Advisor
For Latest Update Follow Us:
